Kidney Disease Clinical Trials

Showing 1241-1260 of 3,902 trials

SAbR For Oligo-Progressive Renal Cell Cancer.

NCT03696277

Metastatic kidney cancer patients on systemic therapy often develop resistance to limited sites that leads to changing of the systemic therapy. Local therapy to the sites of progression may allow patients to continue on the same systemic therapy that is otherwise effective and being tolerated well. Hypothesis: Stereotactic ablative radiation (SAbR) can delay the change of systemic therapy with oligoprogressive renal cell cancer (RCC) and improve progression free survival (PFS). Primary Objectives: • To evaluate the benefit of SAbR for oligo-progressive mRCC (Metastatic Renal Cell Cancer). Secondary Objectives: • To measure the toxicity, safety and tolerance of concurrent systemic therapy and SAbR for mRCC patients and its impact on quality of life.

Oligoprogressive Renal Cell Carcinoma

University of Texas Southwestern Medical Center21 participantsStarted Oct 2018

Dallas, Texas, United States

RECRUITINGNA

Dexamethasone Versus Mg Added to Bupivacaine Used in ESPB for Perioperative Pain Control in Patients Undergoing Unilateral Nephrectomy

NCT06501079

Aim of the study: The current study aims to compare the effect of adding dexamethasone versus magnesium sulfate to bupivacaine in ultrasound-guided erector spinae plane block on the severity of postoperative pain. Primary Objectives: \- To compare the effect of ESPB without additives to the effect of adding dexamethasone and to the impact of adding magnesium sulfate in the form of post-operative morphine consumption

Renal Neoplasm

National Cancer Institute, Egypt78 participantsStarted May 2024

Cairo, Egypt

SAbR For Oligo-Progressive Renal Cell Cancer.

Dexamethasone Versus Mg Added to Bupivacaine Used in ESPB for Perioperative Pain Control in Patients Undergoing Unilateral Nephrectomy

Related Searches

The Underlying Mechanisms Regarding the Effect of Glucagon on the Kidneys Will be Investigated in Healthy Males.

Clinical Outcome of Vinpocetine in Diabetic Nephropathy

Investigating the Safety and Efficacy of SHR6508 Injection in the Treatment of Secondary Hyperparathyroidism in Hemodialysis Patients : A Multicenter, Long-term Clinical Trial

Evaluation of a Multidisciplinary Care Pathway on the Evolution of Renal Function in Patients With Advanced Chronic Kidney Disease

Guo's Visceral Arteries Reconstruction: First in Man Study

Cross-sectional Study to Assess Prevalence and Burden of CKD-associated Pruritus in Haemodialysis Patients

Study of RO7515629 in Participants With HLA-G Positive Solid Tumors

Study to Evaluate the Performance and Safety of Expedial and Compare it to Expanded Polytetrafluoroethylene (ePTFE) Vascular Access Grafts

A Study of XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3)

GRADE-SRM: Genomic Risk Assessment and Decisional Evaluation for Small Renal Masses

Cabometyx and Avelumab in Patients With Metastatic Renal Cell Carcinoma (mRCC)

Serological Testing for COVID-19 (SARS-CoV-2) in ESKD

Plant-Focused Nutrition in Patients With Diabetes and Chronic Kidney Disease

CBM588, Nivolumab, and Ipilimumab in Treating Patients With Stage IV or Advanced Kidney Cancer

Intestinal Transport of Microbial Metabolites in Chronic Kidney Disease

APX005M With Nivolumab and Cabiralizumab in Advanced Melanoma, Non-small Cell Lung Cancer or Renal Cell Carcinoma

Daratumumab-Based Therapy for the Treatment of Newly Diagnosed Multiple Myeloma With Kidney Failure

LONGitudinal Multi-omics Phenotyping of KIDney Function Alteration